Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis

https://www.thelancet.com/journals/landia/article/PIIS2213-8587(24)00102-5/abstract?utm_campaign=update-landia&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_landia&_hsenc=p2ANqtz-_PloOIBlzAmkIwxyhLIHk2bBaJLNc4Bbx2mxXEIVMnb04Y_8yIzKoIxafNUr5iG0AkUNAfZNvQTRvfpzsJ8rv125OO4g&_hsmi=314137961&utm_content=314072467&utm_source=hs_email